V

Vical Incorporated

209 employees

Vical develops biopharmaceutical drugs to prevent and treat chronic or life-threatening infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
infectious disease vaccines
Antifungal
DNA delivery technologies
Herpes
Invasive fungal infection
Genital herpes
HSV-2
Health Care
Infectious diseases
Genetics
Medical
Invasive aspergillosis
Biopharma
HBV
Hepatitis B

Date founded

1987

Funding rounds raised

V

Vical Incorporated raised undisclosed on January 1, 1992

Investors: Venrock

V

Vical Incorporated raised undisclosed on September 29, 1988

Investors: Hilman Ventures and Morgenthaler

FAQ